Shattuck Labs (STTK) Operating Margin (2019 - 2025)
Shattuck Labs' (STTK) quarterly Operating Margin came in at 1071.6% in Q3 2025, down 47367.0% year-on-year from N/an in Q3 2024, and down 79.22% on a QoQ basis from 597.93% in Q3 2024.
Shattuck Labs (STTK) Operating Margin (2019 - 2025) Analysis & Trends
Shattuck Labs (STTK) has 7 years of Operating Margin data on file, last reported at 1071.6% in Q3 2025.
- On a quarterly basis, Operating Margin fell 47367.0% year-over-year to 1071.6% in Q3 2025; TTM through Mar 2026 was 5266.4%, a 364000.0% decrease from a year earlier, with the FY2025 full-year figure at 5150.8%, down 374253.0% from the prior year.
- Operating Margin for Q3 2025 stood at 1071.6%, down from 597.93% in the prior quarter.
- Over the last five years, Operating Margin for STTK reached as high as 30.87% in Q4 2021 and fell as low as 55316.0% in Q2 2022.
- Historically, Operating Margin has averaged 9137.83% across 5 years, with a median of 1797.67% in 2024.
- Across the five-year window, Operating Margin slumped 5473666 bps in 2022 and soared 4394250 bps in 2023, its largest moves.
- Year by year, Operating Margin stood at 30.87% in 2021, then sank by 21929 bps to 6737.44% in 2022, then surged by 61 bps to 2654.2% in 2023, then jumped by 77 bps to 597.93% in 2024, then tumbled by 79 bps to 1071.6% in 2025.
- Per Business Quant data, the three most recent Operating Margin figures were 1071.6% in Q3 2025, 597.93% in Q3 2024, and 1427.1% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,071.60% |
| Sep 30, 2024 | -597.93% |
| Jun 30, 2024 | -1,427.10% |
| Mar 31, 2024 | -1,797.67% |
| Dec 31, 2023 | -2,654.20% |
| Sep 30, 2023 | -4,168.80% |
| Jun 30, 2023 | -11,373.50% |
| Mar 31, 2023 | -38,001.75% |
| Dec 31, 2022 | -6,737.44% |
| Sep 30, 2022 | -11,900.47% |
| Jun 30, 2022 | -55,316.00% |
| Dec 31, 2021 | 30.87% |
| Sep 30, 2021 | -925.26% |
| Jun 30, 2021 | -579.34% |
| Mar 31, 2021 | -547.27% |
| Dec 31, 2020 | -895.01% |
| Sep 30, 2020 | -486.20% |
| Jun 30, 2020 | -198.68% |
| Mar 31, 2020 | -227.18% |
| Dec 31, 2019 | -270.26% |